Skip to main content
HIND logo

HIND · Vyome Holdings, Inc · Metrics

Track HIND — free
$1.84 +0.00 (+0.00%) At close · Oct 21
Market Cap
$12.91M
Shares
7.02M
Volume · Oct 21 2235 Avg daily vol (3M) 12.67K

HIND metrics

73 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.84
Market cap
$12.91M

Price action

20 metrics
Price change (1W)
-6.6%
Price change (30D)
-4.7%
Price change (3M)
-15.6%
Price change (6M)
-18.6%
Price change (YTD)
-46.5%
Price change (1Y)
-66.1%
Trailing year
Price change (5Y)
—
52-week high
$6.31
52-week low
$1.84
Change from 52-week high
-70.8%
Change from 52-week low
+0.0%
Annualized volatility
75.9%
Annualized volatility (3M)
41.4%
Beta
1.2
RSI (14D)
35.9
Price vs SMA 50
-11.5%
Price vs SMA 200
-20.1%
Avg volume (3M)
12,866
Relative volume
0.6
Average dollar volume
$26,700

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
7.02M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 84,585.9%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
99.5×
reciprocal yield 1.0%
P / book
1.8
reciprocal yield 56.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-87.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.3×
reciprocal yield 44.1%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 44.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-06-03

Profitability

9 metrics
Gross margin
52.7%
Operating margin
-9,190.1%
Trailing 12 months
Net margin
-8,716.7%
Gross profit (TTM)
$68,420
Operating profit (TTM)
−$11.92M
Net income (TTM)
−$11.31M
Trailing 12 months
Diluted EPS (TTM)
$1,556.38
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$-68,430.58
Capital expenditures per diluted share (TTM)
$1,027.90
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.64

Growth

11 metrics
Revenue growth YoY
-46.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$129,725
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,733,130.8%
Year over year · more shares
Revenue CAGR (3Y)
-69.5%
Revenue CAGR (5Y)
-51.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-154.7%
Return on assets
-123.2%
Debt / equity
—
Current ratio
4.4
EBITDA (TTM)
−$11.91M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-285.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$7.89M
Total assets
$9.18M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.58M
Capital expenditures (TTM)
$1,425
R&D (TTM)
$1.59M
SG&A (TTM)
$2.68M
Stock compensation (TTM)
$566,875
R&D / revenue
1,226.5%
Stock compensation / revenue
437.0%

Ownership (13F)

9 metrics
13F filers
12
13F filer change QoQ
+3
Institutional ownership
2.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.0%
Private-fund adviser ownership
0.6%
Active holders' share change QoQ
+103.2%
Holder tenure
2.1
Price vs estimated holder cost
-28.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.4%

Short interest

3 metrics
Short interest
0.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1427570 CUSIP 92943X104 Visit website Investor relations